Exciting news from ITOG: Dr. Manisha Shah has been elected to succeed Dr. @DrLoriWirth as the Chair of ITOG after the May 2018 meeting!
ITOG retweeted
Heather Stapleton discussing flame retardants and a potential association with papillary thyroid cancer @ITOGinfo @DukeSurgery. Mechanism?
Thyroid cancer model in zebrafish leads to new insights.Dr.Houvras shares his data, recipient of the inaugural Robert F. Gagel award #itog11
Amazing group of docs and scientists coming together to find a cure for thyroid cancer at ITOG's 11th meeting-this year at DUKE. #itog11
ITOG retweeted
Libby Grubbs from MDACC discussing importance of patient registries for rare diseases like medullary thyroid cancer. @ITOGinfo @DukeSurgery
Fascinating debate on the use of cancer genomics in thyroid cancer at ITOG's annual meeting at Duke. #itog11
ITOG retweeted
Science at #itog11
ITOG retweeted
Discovery at #itog11
Highlights from ITOG's annual meeting hosted by Dr. Julie Ann Sosa at Duke #itog11
ITOG Annual Meeting @ Duke has started.Cari Kitahara (@NIH) reviews JAMA pub: increased incidence of thyroid cancer. jamanetwork.com/journals/jam…
ITOG retweeted
CT - What effect does pregnancy have on the progression of DTC? Read here - #pregnancy #thyroidcancer #thyroid ow.ly/wxzW30ae92C
ITOG retweeted
New #clinicaltrial @MDAndersonNews & throughout US & EU: Phase 2 Lenvatinib for Anaplastic #thyroidcancer
@EisaiUS bit.ly/2jIsCfL
Immune therapy clinical trials coming for patients with thyroid cancer. Exciting new developments discussed at Annual Mtg in Denver.
Exciting new clinical trial uses diabetes drug Actos (pioglitazone) to treat rare subtype of thyroid cancer. clinicaltrials.gov/ct2/show/…
New leadership at ITOG announced by Dr. Steven Sherman: Dr. Lori Wirth (MGH) becomes Chairperson of ITOG!
New leadership at ITOG announced by Dr. Steven Sherman: Dr. Julie Ann Sosa (Duke) elected to the Board of Directors! Congrats Dr. Sosa!
New leadership at ITOG announced by Dr. Steven Sherman: Dr. David Pfister (MSKCC) to chair protocol and join executive committee








